IGM Biosciences Correlations
IGMS Stock | USD 1.28 0.01 0.79% |
The current 90-days correlation between IGM Biosciences and Dyne Therapeutics is 0.21 (i.e., Modest diversification). The correlation of IGM Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
IGM Biosciences Correlation With Market
Modest diversification
The correlation between IGM Biosciences and DJI is 0.27 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding IGM Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Moving against IGM Stock
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between IGM Stock performing well and IGM Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze IGM Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
DYN | 4.10 | 0.27 | 0.06 | 0.33 | 5.57 | 10.08 | 41.63 | |||
EWTX | 2.40 | 0.06 | 0.02 | 0.20 | 3.36 | 5.66 | 22.67 | |||
CGEM | 2.58 | (0.17) | (0.04) | 0.00 | 3.47 | 4.81 | 16.72 | |||
STOK | 2.46 | 0.81 | 0.23 | 1.36 | 2.51 | 7.08 | 21.76 | |||
MLYS | 2.36 | (0.05) | (0.02) | 0.07 | 3.12 | 4.38 | 12.76 | |||
ALXO | 4.06 | 0.06 | 0.01 | 0.21 | 4.22 | 9.43 | 25.96 | |||
SWTX | 1.57 | (0.02) | (0.02) | 0.10 | 2.82 | 5.93 | 20.32 | |||
AKRO | 2.48 | 0.49 | 0.15 | 1.05 | 2.56 | 5.49 | 30.05 |
IGM Biosciences Corporate Management
TS Harigopal | Senior Operations | Profile | |
Faraz Siddiqui | Senior Operations | Profile | |
Angus Sinclair | Senior ImmunoOncology | Profile | |
Elizabeth JD | Senior Property | Profile | |
Elaine Sapinoso | Senior Quality | Profile | |
Misbah CPA | Chief Officer | Profile | |
Lisa Decker | Chief Officer | Profile |